Biotricity, Inc. (BTCY)

1.3300 +0.2100 (+18.75%) At close: 04:00PM EDT

Biotricity, Inc.

275 Shoreline Drive
Suite 150
Redwood City, CA 94065
United States
650 832 1626
https://www.biotricity.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 44

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Waqaas Al-Siddiq Ph.D.	Founder, Pres, CEO & Chairman	597k	N/A	1985
Mr. S. John Ayanoglou	Chief Financial Officer	228k	N/A	1966
Dr. George N. Nikopoulos	Director of Bus. Devel.	N/A	N/A	N/A
Mr. Amir Ali	Chief Devel. Officer	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Biotricity, Inc., medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated electrocardiogram (ECG) device and software solution. The company is based in Redwood City, California.

Corporate Governance

Biotricity, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.